This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Trading Volatile Big Pharma Stocks

Here are the buy-and-trade parameters for 12 Big Pharma stocks:

Abbott Labs (ABT - Get Report) ($35.36) set a multi-year high at $38.77 on May 22. My monthly value level is $22.38 with a weekly risky level at $36.76.

Allergan (AGN - Get Report) ($85.43) set a 2013 low at $81.33 on June 24. My weekly pivot is $86.72 with a semiannual risky level at $88.65.

AstraZeneca (AZN - Get Report) ($47.99) set a multi-year high at $53.45 on May 28, then fell to $46.87 into June 24. My annual value level is $42.53 with a quarterly risky level at $49.43.

Bristol-Myers Squib (BMY - Get Report) ($46.30) set a multi-year high at $49.57 on June 3. My quarterly value level is $43.35 with a weekly risky level at $49.31.

GlaxoSmithKline (GSK - Get Report) ($50.10) set a multi-year high at $54.00 on May 28, then a low of $48.30 on June 24. My monthly value level is $47.78 with a weekly pivot at $50.57 and quarterly risky level at $51.33.

Johnson & Johnson (JNJ) ($86.71) set a multi-year high at $89.99 on May 22, then as low as $82.12 on June 20. My monthly value level is $85.71.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABT $38.55 -0.77%
AGN $214.82 -1.51%
BMY $71.13 -1.15%
AZN $28.92 -1.23%
GSK $43.14 -0.35%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs